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Nonstructural protein 15 (Nsp15) of the severe acute respiratory syndrome coronavirus (SARS-CoV) pro-
duced in Escherichia coli has endoribonuclease activity that preferentially cleaved 5 of uridylates of RNAs.
Blocking either the 5 or 3 terminus did not affect cleavage. Double- and single-stranded RNAs were both
substrates for Nsp15 but with different kinetics for cleavage. Mn2 at 2 to 10 mM was needed for optimal
endoribonuclease activity, but Mg2 and several other divalent metals were capable of supporting only a low
level of activity. Concentrations of Mn2 needed for endoribonuclease activity induced significant conforma-
tion change(s) in the protein, as measured by changes in tryptophan fluorescence. A similar endoribonucleo-
lytic activity was detected for the orthologous protein from another coronavirus, demonstrating that the
endoribonuclease activity of Nsp15 may be common to coronaviruses. This work presents an initial biochemical
characterization of a novel coronavirus endoribonuclease.
The severe acute respiratory syndrome (SARS) epidemic of
2002 to 2003 eventually spread from China to 30 countries,
with more than 8,000 confirmed cases and an overall mortality
rate of about 10% (31). Due to the lack of more specific an-
tiviral agents, one treatment regimen used consisted of corti-
coid steroids and ribavirin (15, 16). This regimen was of un-
known efficacy and had severe side effects. Thus, there is a
need for better therapeutic strategies and the development of
potential targets in the etiological agent of SARS.
SARS is caused by a coronavirus (SARS-CoV), which has a
positive-strand RNA genome of 30 kb in length with a 5 cap
and 3 poly(A) tail (22). For general reviews of coronaviruses,
see Lai and Cavanagh (13) and Spaan et al. (26). Of the three
coronavirus phylogenetic groups, groups 1 and 2 infect mam-
mals, causing respiratory, central nervous system, enteric, and
even systemic infections, while group 3 infects birds. Phyloge-
netic analysis of the SARS-CoV RNA-dependent RNA poly-
merase sequence has placed SARS-CoV in group 2 (25). Anal-
ysis of the complete genomes of more than a dozen SARS-
CoV isolates from around the world indicate that SARS-CoV
is not a mutant or recombinant of known coronaviruses, but a
novel coronavirus that acquired the ability to infect humans. A
nearly identical coronavirus was isolated from civet cats, rac-
coon dogs, and badgers, an observation that raises speculations
that this virus jumped species to humans (4).
Coronavirus produces two large polyproteins that are pro-
teolytically processed to yield replication-associated proteins
and several structural and infection-associated proteins that
are translated from subgenomic RNAs (Fig. 1). The coronavi-
rus proteases that are required for processing of the polypro-
teins have been characterized extensively (1, 32). In addition,
the structure of SARS-CoV nonstructural protein 9 (Nsp9)
was solved recently and is a novel RNA binding protein (27).
Nsp13 is a helicase with the ability to unwind both DNA and
RNA duplexes. Nsp13 is also reported to have dNTPase and
RNA 5-triphosphatase activities (6).
In general, the biochemical characterizations of the coro-
navirus replication-associated proteins are at an early stage.
Snijder and colleagues have proposed that Nsp15 has similar-
ities to the endoribonuclease XendoU (25), a Mn2-depen-
dent endoribonuclease required for the biogenesis of U16
small nucleolar RNA (3, 14). The predicted secondary struc-
tures of the two proteins have few similarities (C. C. Kao,
unpublished observations), but the SARS-CoV Nsp15 is rich in
acidic residues (46 of 346 total residues are aspartates or glu-
tamates) that could coordinate metal cofactor(s). These obser-
vations prompted us to examine whether Nsp15 is indeed an
endoribonuclease. Furthermore, Nsp15 orthologs of coronavi-
ruses are well conserved at the N and C termini but are more
divergent in the central portion (Fig. 1), raising the question of
whether orthologs in different coronaviruses have a common
enzymatic activity. In this work, we report the production of a
recombinant version of the SARS-CoV Nsp15 protein and
provide biochemical evidence that it is indeed an Mn2-de-
pendent endoribonuclease that cleaves 5 of uridylates.
MATERIALS AND METHODS
Protein expression and purification. The SARS-CoV Nsp15 cDNA was am-
plified by reverse transcription-PCR (RT-PCR) using RNAs extracted from the
Urbani isolate of SARS-CoV using oligonucleotides D23.3 and D29.2 (Table 1).
RT-PCR was performed using a kit provided by Invitrogen following the proto-
col suggested by the manufacturer. The PCR product was cloned into the vector
pET15b to provide an N-terminal six-histidine tag to facilitate purification of the
SARS-CoV Nsp15. The DNA sequence was determined in its entirety to confirm
its identity to the one reported by Rota et al. (22) (accession number AY278741).
Similar procedures were used to amplify the cDNAs coding for the orthologs of
mouse hepatitis virus (MHV) (A59 strain) and infectious bronchitis virus (IBV)
(Beaudette strain).
Bacterial cultures were grown at 37°C in standard Luria-Bertani medium
supplemented with 50 g of ampicillin per ml until the culture reached an optical
density at 600 nm of 1.0. The culture temperature was then lowered to 16°C, and
expression was induced for 36 h with 1 mM isopropyl-thiogalactoside. Cells were
harvested after centrifugation, and recombinant proteins were purified in buffer
lacking divalent metals by passage through a Talon nickel affinity column (In-
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vitrogen, Inc.), followed by gel filtration through Superdex 75 (Pharmacia, Inc.)
or an ion-exchange (Mono Q) column (Pharmacia, Inc.). The protein was ad-
justed to 0.1 mg/ml after quantification by staining with Coomassie blue using
bovine serum albumin as a concentration control and stored in buffer containing
50 mM Tris (pH 7.5) and 50% glycerol.
Preparation of endoribonuclease substrates. DNA oligonucleotide D23.2 was
synthesized by GeneSys (Sigma, Inc., St. Louis, Mo.). Oligoribonucleotides were
either chemically synthesized by Dharmacon, Inc. (Boulder, Colo.), or tran-
scribed by use of the T7 RNA polymerase as described previously (8). Unless
stated otherwise, substrates used for cleavage assays were labeled at the 5 end
FIG. 1. Schematic of the SARS-CoV genome and the sequence of Nsp15. The approximate locations of polyproteins 1a (pp1a) and 1ab (pp1ab)
in the SARS-CoV genome are indicated. Proteins made from subgenomic messages encoded by the 3 portion of the SARS-CoV genome are
shown. For clarity, the individual coding sequences are not shown. The Nsp15 sequence is from the Urbani isolate and is represented by the
standard one-letter code. Comparable sequences from MHV and IBV were aligned with the CLUSTAL program (28). Residues that have identical
side chains (asterisks), functionally similar side chains (colons), and somewhat similar side chains (periods) are indicated under the sequences.
Gaps introduced to maximize alignment are indicated by dashes. The central portion of the MHV protein is more divergent than the comparable
sequence from the SARS-CoV and IBV proteins. To help demonstrate the possible relevance of the alignments, the PHD program (21) was used
to predict the positions of secondary structures predicted within each polypeptide. The residues putatively involved in the formation of -strands
or -helices are underlined or shaded, respectively. Sequences under the thick black lines represent the region with similarities to the putative
XendoU active site, as described by Snijder et al. (25).
TABLE 1. Oligonucleotides and RNAs used in this study
Oligonucleotide or RNA Orientation Use Sequence
DNA oligonucleotides
D23.3 5 PCR-SARS-CoV 5 CATATGAGTTTAGAAAATGTGGC 3
D29.2 3 RT-PCR, SARS-CoV 5 GGATCCTTATTGTAGTTTTGGGTAGAAGG 3
D27.2 5 PCR, IBV 5 ACATATGTCTATCGACAATATTGCTTA 3
D27.3 3 RT-PCR, IBV 5 ACTCGAGTTGAAGCTGTGGATAACATG 3
D27.4 5 PCR, MHV 5 ACATATGAGTTTAGAAAATGTAGTGTA 3
D27.5 3 RT-PCR, MHV 5 ACTCGAGCTGCAAACGAGGATAGAAAG 3
Chemically synthesized RNAs
R10.2 Nsp15 substrate 5 UGGGAGUAUA 3
R12 Nsp15 substrate 5 CCCCCGCCCCCC 3
SK21 Nsp15 substrate 5 GACGCUGAAUUAGGACAUAGA 3
LE19P Nsp15 substrate 5 UGUUAUAAUUAUUGUAUAC-puromycin 3
F16.2 Nsp15 substrate 5 fluorescein-GGUCAGGAUACCUGGC 3
LE21 Nsp15 substrate 5 UGUUAUAAUUAUUGUAUAUAC 3
T7 RNA polymerase transcript SL13 Nsp15 substrate 5 GGUGCAUAGCACC 3
Double-stranded RNA ds34 Nsp15 substrate 5 UGUUAUAAUUAUUGUAUAUACAAUAAUUAUAACU 3
3 ACAAUAUUAAUAACAUAUAUGUUAUUAAUAUUGA 5
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with T4 polynucleotide kinase and [-32P]ATP. Prior to labeling reactions, all
RNAs were purified from denaturing 7.5 M urea–20% polyacrylamide gels (20:1
acrylamide to bisacrylamide) by the method of Ranjith-Kumar et al. (18). Dou-
ble-stranded RNA ds34 was made by extending from two partially annealed
molecules of RNA LE21 using the hepatitis C virus RNA-dependent RNA
polymerase by the method of Ranjith-Kumar et al. (17).
Endoribonuclease assays. The standard RNA cleavage assay used 10,000 cpm
of radiolabeled RNA substrate (final RNA concentration of 20 M) and 0.26
M Nsp15 in a buffer consisting of 50 mM Tris (pH 7.5), 100 mM KCl, 1 mM
dithiothreitol, and 5 mM MnCl2. The reaction mixture was incubated at 30°C for
30 min unless stated otherwise. The reactions were terminated by the addition of
the gel-loading buffer that contained 7.5 M urea. Products were usually separated
by electrophoresis in denaturing gels composed of 7.5 M urea and polyacryl-
amide. Gels were wrapped in plastic and exposed to a PhosphorImager screen.
Each result shown was reproduced in at least one and usually two independent
experiments. Quantification of radiolabeled bands was performed using a Phos-
phorImager (Molecular Dynamics).
Intrinsic fluorescence measurements. All fluorescence measurements were
made using Perkin-Elmer luminescence spectrometer LS55 and cuvette (Perkin-
Elmer) with an optical path length of 0.4 cm at room temperature (22 to 23°C).
Nsp15 protein was at 0.5 M in a buffer containing 50 mM Tris (pH 7.5) and
100 mM KCl. When divalent metal was added during titration, the final volume
did not exceed 10% of the initial sample volume. The samples were excited with
light at a wavelength of 295 nm, and the emission was scanned with light at a
wavelength from 310 to 450 nm (slit widths of excitation and emission were 5 and
10 nm, respectively). The emission scan was repeated three times, and all results
were averaged. All data were corrected for the background intensity of the buffer
and for dilution. Binding data were analyzed by nonlinear least-squares fitting
using KaleidaGraph software (Synergy Software, Reading, Pa.). A simple 1:1
binding model was fitted to the binding isotherm using equation 1: F/F0 	 Bmax
[ligand]total/(Kd  [ligand]total), where F is the magnitude of the difference
between the observed fluorescence intensity (arbitrary unit) at a given metal ion
concentration and the fluorescence intensity in the absence of metal ions, F0 is
the fluorescence intensity in the absence of metal ions, and Bmax is the value of
the maximum relative fluorescence change.
RESULTS
Endoribonuclease activity. Recombinant SARS-CoV Nsp15
was expressed with six N-terminal histidine residues and puri-
fied from Escherichia coli BL21star (deficient in RNase E ac-
FIG. 2. Purification and endoribonucleolytic activity of Nsp15. (A) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the recom-
binant SARS-CoV purified from a Ni-NTA column. Nsp15 was loaded at two concentrations, and the gel was stained with Coomassie brilliant blue.
The positions (in kilodaltons) of molecular mass markers (M) are shown to the left of the gel. (B) A gel image demonstrating the cleavage of a
radiolabeled 10-nt RNA and nucleotide resolution of the cleavage products. Nsp15 was added to one master reaction mixture, and aliquots of the
reaction mixture were removed at the times shown above the gel image for electrophoresis in a 7.5 M urea–20% polyacrylamide gel. The sequence
of the RNA substrate, R10.2, is shown above the gel, and the sizes of the bands (in nucleotides) are indicated to the left of the gel. The percentage
of the 10-nt R10.2 that remains after each treatment (% FL) is indicated under the gel. The smaller gel at the right shows that R12, which lacks
uridylates, is not cleaved to the same extent as R10.2. (C) Copurification of the endoribonucleolytic activity with the recombinant protein. The
protein enriched from the metal affinity column was fractionated over a Mono Q column, with Nsp15 eluting primarily in fractions 17 and 18. The
amount of endoribonucleolytic activity in the fraction (% Activity) is indicated. The activities in these column fractions were normalized to that
of fraction 17 (set at 100%). (D) Sequences of SK21 and potential products that can be generated from a DNA template coding for SK21 by the
T7 RNA polymerase when UTP is absent. (E) Cleavage of a radiolabeled RNA SK21. The percentage of the full-length substrate RNA remaining
after each treatment (% FL) is indicated under the gel. Lanes where the input RNA was not treated with Nsp15 (
) are indicated above the gel.
(F) Analysis of the cleavage site preferred by Nsp15. The final product generated by Nsp15 from SK21 should be 5 nt long if cleavage occurs 5
of uridylates. If cleavage occurs 3 of uridylates, the stable product should be 6 nt long. To examine the length of the stable Nsp15 product, DNA
template T7-SK21 was used to transcribe RNA products in the absence of UTP. T7 polymerase should generate an abundant 5-nt RNA product.
Other slightly longer products could be accounted for by terminal nucleotide addition and/or nucleotide misincorporation. End-labeled SK21 RNA
was treated with Nsp15 for 1 h () or left alone () (lanes 1 and 2) as described above. To confirm the length of the Nsp15 cleavage product,
T7 transcription was performed in the absence of UTP using template T7-SK21 as described above for panel F (lane 3). Samples from lanes 1 and
3 were mixed together and loaded in lane 4 to show that both products are the same length.
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tivity) (Fig. 2A). Expression of the protein was higher in E. coli
BL21star strain than in E. coli BL21(DE3) (K. Bhardwaj, data
not shown), with approximately 10% of the overexpressed pro-
tein in the soluble fraction after centrifugation at 10,000  g.
The recombinant protein had the expected mass and bound to
Ni-nitrilotriacetic acid (NTA) resin. The bound sample was
washed with a buffer containing 25 mM imidazole before elu-
tion with a buffer containing 250 mM imidazole (Fig. 2A).
To monitor enzymatic activity, we incubated Nsp15 with a
10-nucleotide (nt)-long RNA named R10.2 that was radiola-
beled at the 5 phosphate. This RNA contains three uridylates
(Table 1 and Fig. 2B). Should Nsp15 cleave the phosphodiester
bond 5 of the uridylate, radiolabeled products of 8 and 6 nt
would result from partial digestion (Table 1). There is also a
minor amount of a 9-nt RNA in this preparation that arose
from incomplete chemical synthesis of R10.2. We also used a
12-nt RNA named R12 that lacked uridylates. When incubated
for up to 40 min in a buffer containing 5 mM Mn2, a concen-
tration optimal for XendoU (3), the amount of full-length
R10.2 decreased over time, and 6- and 8-nt cleavage products
accumulated. Cleavage was not observed in reactions lacking
divalent metal, and R12 was not cleaved under the same con-
ditions (Fig. 2B and data not shown). These results suggest that
Nsp15 is an endoribonuclease that preferentially cleaves 5 of
uridylates and that endoribonucleolytic activity requires diva-
lent metal. These specific requirements will be confirmed and
characterized further below.
To demonstrate further that endoribonucleolytic activity is
the property of the recombinant Nsp15, we monitored this
activity in Nsp15 preparations fractionated by additional chro-
matography columns. In a Mono Q ion-exchange column, ac-
tivity copurified with the peak of Nsp15 protein (Fig. 2C).
Endoribonucleotytic activity also copurified with Nsp15 frac-
tionated by gel filtration through Superdex 75 (data not shown).
To confirm that Nsp15 specifically cleaves 5 of uridylates,
we examined the digestion pattern for a second RNA, SK21,
which contained four uridylates (Fig. 2D). Over a period of 30
min, four fragments were produced (Fig. 2E), as would be
expected if Nsp15 were to cleave at uridylates. Complete di-
gestion of SK21 5 of uridylates should result in a radiolabeled
RNA fragment 5 nt long. To determine whether cleavage oc-
curred 5 or 3 of the uridylates, we compared the mobility of
the smallest fragment generated upon digestion of SK21 with
5-nt RNA made by in vitro transcription of SK21 in the ab-
sence of UTP. The two RNAs comigrated in a denaturing gel,
demonstrating that Nsp15 cleaved 5 of a uridylate residue
(Fig. 2F). The requirement for divalent metals, the preferred
cleavage 5 of uridylates in RNAs, and the copurification of
activity with the protein indicate that Nsp15, and not a con-
taminating protein, is an endoribonuclease.
Specificity for RNA. To determine whether Nsp15 cleavage
is specific for RNAs, a 5-end-labeled DNA molecule (D23.2)
of 23 nt that contained all four bases was incubated with Nsp15
at standard assay conditions. D23.2 was not cleaved by Nsp15
(Fig. 3A). Furthermore, D23.2 did not inhibit Nsp15-mediated
cleavage of R10.2 (Fig. 3B), suggesting that Nsp15 does not
stably bind DNA.
We sought to identify an inhibitor for Nsp15. Many nucleic
acid binding proteins, such as polymerase, are inhibited by hep-
arin, a polysulfonate that mimics nucleic acid (9). When hep-
arin was present in the reaction mixture at 0.01 to 5 g, Nsp15
cleavage of R10.2 was inhibited approximately two- to three-
fold (Fig. 3B). This result suggests that heparin can be used for
future characterizations of Nsp15-substrate interactions.
Requirements for divalent metals. We characterized further
the role of divalent metal ions in Nsp15 activity. The ability to
cleave R10.2 was determined under a range of Mn2 and
Mg2 concentrations (Fig. 4A). Increasing the concentration
of Mn2 from 0 to 10 mM increased ribonucleolytic activity
more than 50-fold. Furthermore, only minimal activity was
observed with Mg2 or several other divalent metals (Fig. 4A
and B). The requirement for Mn2 at concentrations higher
than 1 mM and the inability to cleave RNA in the presence of
Mg2 were also observed with other RNAs (data not shown).
The SARS-CoV Nsp15 protein thus exhibits a strong prefer-
ence for Mn2 as a cofactor for RNA cleavage.
To determine whether Mn2 affects the conformation of
Nsp15, we measured its intrinsic tryptophan fluorescence.
There are three tryptophans in the SARS-CoV Nsp15, two in
the N-terminal region and one near the C terminus. A scan
performed in the absence of divalent metals revealed that
337 nm was the wavelength for maximal emission. Titration of
Mn2 resulted in a significant decrease in tryptophan signal,
indicating that a conformational change(s) is taking place (Fig.
4C). Buffer lacking Nsp15, but containing Mn2 at concentra-
tions up to 20 mM, contributed minimally to the measure-
FIG. 3. Interaction of Nsp15 with DNA and heparin. (A) PhosphorImage of 7.5 M urea–20% polyacrylamide gel showing 5-end-labeled DNA
oligonucleotide (D23.2) incubated in the presence () or absence () of Nsp15 under standard assay conditions. Each treatment was done in
triplicate. (B) Effects of heparin and DNA on cleavage of R10.2 RNA by Nsp15. R10.2 digestion was performed in the absence or presence of
various concentrations of either heparin or DNA (indicated above the bars). After the RNAs were resolved on urea-polyacrylamide gels, uncleaved
R10.2 was quantitated and shown as a percentage [FL (%)]. Substrate RNA incubated in the absence () of Nsp15 was set at 100%. Each error
bar represents 1 standard deviation from the mean for each treatment.
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ments. In addition, Mg2 was unable to induce the same level
of change in Nsp15 intrinsic fluorescence (Fig. 4C). The degree
of conformational change correlated well with the concentra-
tions needed for endoribonuclease activity (Fig. 4A), suggest-
ing that Mn2 association with Nsp15 resulted in the formation
of an enzyme capable of endoribonucleolytic activity.
The rate of change in intrinsic tryptophan fluorescence, cor-
rected for buffer effects, was used to calculate the dissociation
constant for Mn2. A 1:1 binding model was found to fit the
data well, generating an R2 value of 0.98. The calculated Kd for
Mn2 was 5.3 mM (Fig. 4D).
Substrate requirements. The cleavage pattern with RNA
R10.2 suggests that Nsp15 is an endoribonuclease. Next, we
determined whether an accessible 5 or 3 terminus was needed
for RNA cleavage using two previously characterized RNAs
named F16.2 and LE19P that have fluorescein and puromycin,
respectively, covalently attached to the 5 or 3 terminus (12,
17). LE19P has an accessible 5 terminus that was radiolabeled
with kinase. In a standard cleavage reaction, the degradation
kinetics of LE19P was identical to that of LE19 (Fig. 5A and
data not shown). F16.2 cannot be 5 end labeled due to the
fluorescein and so was visualized by staining with toluidine
blue. F16.2 was cleaved and with kinetics similar to that of
unmodified RNA (Fig. 5A and data not shown). These results
indicate that blocked 5 and 3 termini do not significantly
affect RNA cleavage by the SARS-CoV Nsp15, consistent with
Nsp15 being an endoribonuclease.
RNA substrates tested thus far do not have extensive stable
structures, as predicted by the Mfold computer program (33)
and according to previous characterizations of these RNAs
(18). To determine whether structures in RNA affect Nsp15 ac-
tivity, we produced an internally labeled 34-nt double-stranded
RNA named ds34 that was generated by primer-dependent
extension from two molecules of RNA LE21 (18). The ds34
was cleaved slightly slower than LE21 was (Fig. 5B). Last, we
observed that an unusually stable RNA hairpin named SL13
that contains a 5-bp stem and a 3-nt loop with an uridylate
(Table 1) (11) was digested by Nsp15 at a significantly reduced
rate (Fig. 5B). These results demonstrate that in vitro, Np15 is
catalytically active on RNAs that are single or double stranded.
However, there are differences in the rates of cleavage that
FIG. 4. Requirements for divalent metal ions for SARS-CoV en-
doribonucleolytic activity. (A) Mg2 and Mn2 concentrations needed
for endoribonucleolytic activity of Nsp15. RNA R10.2 was used as the
substrate in the titrations. All divalent metals used in this figure were
in the form of chloride salts. (B) Examination of the effects of other
divalent metals on cleavage of R10.2 by Nsp15. The effects of several
divalent metals (at 0.5 or 5 mM) were quantified and are shown below
the gel. Only the full-length RNA (FL) is shown. 
 indicates no
divalent ion. (C) Effects of Mn2 on the spectroscopic properties of the
SARS-CoV Nsp15. Change in intrinsic fluorescence (FU) of Nsp15 in
response to increasing Mn2 concentration. The emission maximum of
Nsp15 was determined to be at 337 nm. Scans at increasing concen-
trations of divalent metal were taken, and values at 337 nm were
plotted. (D) Modeling of the binding constant for Mn2. A 1:1 model
was fitted to the binding isotherm to derive Kd using equation 1 (see
Materials and Methods).
FIG. 5. Substrate requirements for endoribonucleolytic activity of
SARS-CoV Nsp15. (A) RNA substrates with chemically modified 3
and 5 termini. RNA LE19P, with a covalently attached 3 puromycin
is a weakly base-paired RNA that could form a weakly stable intramo-
lecular hairpin or partially base-paired dimer (19). F16.2 is a 16-nt
RNA that was synthesized with a 5 fluorescein. The amount of cleav-
age was normalized to the percentage of full-length RNA remaining
after the treatment (% FL). The RNA used in each experiment and
whether Nsp15 was added () or not () are indicated above the gels.
Digestion of LE19P is shown as a PhosphorImage of radiolabeled
RNA, while F16.2 was from a toluidine blue-stained gel. (B) Compar-
ison of the rate of cleavage of single- and double-stranded RNAs. ds32
is a double-stranded RNA with complete complementarity in the two
strands. LE21, a single-stranded RNA with minimal intramolecular
base pairing, was used to generate ds34. The amount of each input
RNA was normalized to 100%. SL13, a 13-nt RNA was produced by in
vitro transcription by use of T7 polymerase. 5-end phosphate was
replaced with radiolabeled phosphate by sequential treatment with
alkaline phosphatase and T4 polynucleotide kinase. Radiolabeled
RNA was gel purified before use.
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may be significant in the regulation of Nsp15 activity during
SARS-CoV infection.
Activity of other coronavirus orthologs. The SARS-CoV has
a number of unique open reading frames (22), and the central
region of Nsp15 appears to be more divergent than the or-
thologs of MHV and IBV (Fig. 1). To address whether endori-
bonucleolytic activity of Nsp15 is a common property of coro-
naviruses or is unique to the SARS-CoV, the corresponding
proteins from MHV and IBV were engineered with histidine
tags and purified by the same protocol as the protein from
SARS-CoV. Since the corresponding proteins from different
viruses were given different names, we will refer to them as
orthologs. When tested for the ability to cleave R10.2, the IBV
ortholog did so and with kinetics faster than the protein from
the SARS-CoV (Fig. 6A). There was also an increase in the
degradation of the 8- and 6-nt cleavage intermediates (Fig.
6A). The IBV ortholog also cleaved SK21 with kinetics similar
to that of the SARS-CoV Nsp15 (data not shown). In contrast,
two independently constructed orthologs from MHV were
much less efficient in this activity (Fig. 6B); cleavage by the
MHV ortholog was reproducible and reduced the amount of
R10.2 by only 15 to 20%. These results demonstrate that while
the endoribonuclease activity of the SARS-CoV Nsp15 is not
unique among coronaviruses, the amount of activity could dif-
fer in proteins from different viruses, at least in vitro.
DISCUSSION
Characterization of the biochemical activities of the proteins
in the SARS-CoV is a necessary first step toward identifying
molecular targets for antiviral agents. In this work, we have
established that the replication-associated Nsp15 protein has
endoribonucleolytic activity with properties that resemble
those of the Xenopus laevis XendoU (3, 14), as predicted by
Snijder and colleagues (25). Nsp15 preferentially cleaved 5 of
uridylates and was insensitive to modifications at both the 5
and 3 ends of the RNA substrate. In addition, it can cleave
single- and double-stranded RNAs in a manganese-dependent
reaction but with notable differences in the rates of cleavage.
The concentrations of Mn2 needed for catalysis caused a
significant change in the tryptophan fluorescence of Nsp15, sug-
gesting that Mn2 could induce a conformational change in
Nsp15, perhaps leading to the catalytically active form. Last, the
demonstrated activity was not unique to the SARS-CoV but was
also observed in the IBV ortholog. Whether MHV Nsp15 pos-
sesses the identical activity requires additional characteriza-
tions. RNA endoribonuclease activity is unusual among plus-
strand RNA viruses. One other example is found in the nega-
tive-strand influenza virus, which encodes a specific endoribo-
nuclease that is involved in cleaving capped cellular transcripts
(20). This unique nature of Nsp15 for SARS-CoV suggests that
it could be a target for the development of antiviral agents.
A number of Mn2-dependent endoribonucleases have pre-
viously been characterized, including retroviral and cellular
RNase H (5), which selectively degrades the RNA strand du-
plexed to DNA. E. coli RNase H has a single Mg2 in the
active site, while the one from the human immunodeficiency
virus uses two Mn2 that are coordinated by a network of
negatively charged amino acid side chains. Nsp15 likely coor-
dinates Mn2 by a combination of acidic side chains, although
the ones participating in metal binding and the residues that
participate in nucleophilic attack of the phosphodiester back-
bone remain to be identified.
Interestingly, E. coli RNase H is active with micromolar con-
centrations of Mn2 but requires millimolar levels of Mg2, lead-
ing to the proposal that two metal ions are bound, with the first
activating the enzyme and the second inhibiting its activity (10).
However, unlike E. coli RNase H, Nsp15 does not appear to be
inhibited by high concentrations of Mn2 and is not partic-
ularly active with any concentration of Mg2. Nonetheless,
since the concentration of Mn2 needed for Nsp15 endoribo-
nucleolytic activity (millimolar) is not physiologically relevant,
we cannot rule out additional roles of divalent metals in reg-
ulating Nsp15 activity. We note, however, that XendoU also
requires millimolar amounts of Mn2 in vitro (14), again indi-
cating that the two proteins have similar activities. It would not
be surprising to learn that the intracellular environment could
influence the Kd for divalent metal requirements for Nsp15.
FIG. 6. Comparison of endoribonuclease activities of the SARS-CoV Nsp15 and orthologs from other coronaviruses. (A) Activities of the IBV
ortholog. An image of the cleavage products from R10.2 and R12 are shown. The proteins and RNA substrates used in each reaction mixture are
indicated above the gel. The contents of all lanes were exposed to Nsp15, but an aliquot was removed and placed in the denaturing gel loading
buffer within seconds of addition of the enzyme (1 min). The sizes of the products (in nucleotides) are indicated to the left of the gel.
Quantification of endoribonuclease activity, shown below the gel, refers to the percentage of the full-length RNA (% FL) remaining in each lane.
(B) Activity of the MHV ortholog.
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Hence, it is possible that physiological concentrations of Mn2
are sufficient for Nsp15 activity in the SARS virus replication/
transcription complex or that the availability of divalent met-
al(s) provides a means to regulate the activity of this enzyme.
How could an RNA endoribonucleolytic activity function in
coronavirus infection? One possibility is that Nsp15 contrib-
utes to pathogenesis by affecting cellular RNA processing.
Another possibility is that Nsp15 plays a role in coronavirus
replication and/or transcription (24, 32). It has been suggested
that coronavirus subgenomic RNA synthesis requires nuclease
activity (2, 7, 29). Coronaviruses produce between five and
eight subgenomic RNAs whose 3 ends are coterminal with the
3 end of the plus-strand genomic RNA. Interestingly, despite
being of different lengths, the subgenomic RNAs share a com-
mon 5 leader of 65 to 98 nt. How the leader is attached to the
body of the mRNA is still under investigation, but two models
are generally invoked. The first, the leader-primed model (13),
posits that the leader RNA is synthesized from the 3 end of
the genomic minus-strand RNA, released by the viral tran-
scriptase, and primes RNA synthesis at the intergenic sites in
the minus-strand template RNA. The precursor leader RNAs
tend to be longer than the version fused to the body RNA,
suggesting that it is processed prior to the priming reaction (7).
Such processing could use Nsp15. In the second model, the
discontinuous transcription model, it is hypothesized that the
replicating polymerase ternary complex translocates at specific
intergenic sequences during minus-strand RNA synthesis and
then reattaches to the 5 leader sequence and resumes RNA
synthesis (23). It is also possible that an endoribonuclease
activity is required to digest the nascent RNA to untether the
ternary complex prior to the translocation of the ternary poly-
merase complex. How Nsp15 affects the SARS-CoV infection
process remains to be determined.
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